Integrating opposing signals toward forkhead Box O

Antioxidants and Redox Signaling

Volumn 14, Issue 4, 2011, Pages 607-621

  Van Den Berg, Maaike C W ^a   Burgering, Boudewijn M T ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR FOXO;

CELL FATE; GENETIC TRANSCRIPTION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; REVIEW; SIGNAL TRANSDUCTION; UBIQUITINATION;

ANIMALS; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; MODELS, BIOLOGICAL; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 79251548012     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2010.3415     Document Type: Review

References (120)

1. Aguirre V, Uchida T, Yenush L, Davis R, and White MF. The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307). J Biol Chem 275: 9047-9054, 2000.
2. Aigaki T, Seong KH, and Matsuo T. Longevity determination genes in Drosophila melanogaster. Mech Ageing Dev 123: 1531-1541, 2002.
3. Altomonte J, Cong L, Harbaran S, Richter A, Xu J, Meseck M, and Dong HH. Foxo1 mediates insulin action on apoC-III and triglyceride metabolism. J Clin Invest 114: 1493-1503, 2004.
4. Andjelkovic M, Jakubowicz T, Cron P, Ming XF, Han JW, and Hemmings BA. Activation and phosphorylation of a pleckstrin homology domain containing protein kinase (RAC-PK/PKB) promoted by serum and protein phospha-tase inhibitors. Proc Natl Acad Sci USA 93: 5699-5704, 1996.
5. Aoki M, Jiang H, and Vogt PK. Proteasomal degradation of the FoxO1 transcriptional regulator in cells transformed by the P3k and Akt oncoproteins. Proc Natl Acad Sci USA 101: 13613-13617, 2004.
6. Asada S, Daitoku H, Matsuzaki H, Saito T, Sudo T, Mukai H, Iwashita S, Kako K, Kishi T, Kasuya Y, and Fukamizu A. Mitogen-activated protein kinases, Erk and p38, phos-phorylate and regulate Foxo1. Cell Signal 19: 519-527, 2007.
7. Bakker WJ, Blazquez-Domingo M, Kolbus A, Besooyen J, Steinlein P, Beug H, Coffer PJ, Lowenberg B, von Lindern M, and Van Dijk TB. FoxO3a regulates erythroid differentiation and induces BTG1, an activator of protein arginine methyl transferase 1. J Cell Biol 164: 175-184, 2004.
8. Barreto G, Schafer A, Marhold J, Stach D, Swaminathan SK, Handa V, Doderlein G, Maltry N, Wu W, Lyko F, and Niehrs C. Gadd45a promotes epigenetic gene activation by repair-mediated DNA demethylation. Nature 445: 671-675, 2007.
9. Barthel A, Schmoll D, and Unterman TG. FoxO proteins in insulin action and metabolism. Trends Endocrinol Metab 16: 183-189, 2005.
10. Berriot-Varoqueaux N, Aggerbeck LP, Samson-Bouma M, and Wetterau JR. The role of the microsomal triglygeride transfer protein in abetalipoproteinemia. Annu Rev Nutr 20: 663-697, 2000.
11. Bertoli C, Copetti T, Lam EWF, Demarchi F, and Schneider C. Calpain small-1 modulates Akt/FoxO3A signaling and apoptosis through PP2A. Oncogene 28: 721-733, 2009.
12. Bi W, Xiao L, Jia Y, Wu J, Xie Q, Ren J, Ji G, and Yuan Z. C-jun N-terminal kinase enhances MST1-mediated pro-apoptotic signaling through phosphorylation at Serine 82. J Biol Chem 285: 6259-6264, 2010.
13. Biggs WH 3rd, Meisenhelder J, Hunter T, Cavenee WK, and Arden KC. Protein kinase B/Akt-mediated phosphor-ylation promotes nuclear exclusion of the winged helix transcription factor FKHR1. Proc Natl Acad Sci USA 96: 7421-7426, 1999.
14. Brenkman AB, de Keizer PLJ, Van den Broek NJF, Jo-chemsen AG, and Burgering BMT. Mdm2 induces mono-ubiquitination of FOXO4. PLoS ONE 3: e2819, 2008.
15. Brenkman AB, de Keizer PLJ, Van den Broek NJF, Van der Groep P, Van Diest PJ, Van Der Horst A, Smits AMM, and Burgering BMT. The peptidyl-isomerase Pin1 regulates p27kip1 expression through inhibition of Forkhead box O tumor suppressors. Cancer Res 68: 7597-7605, 2008.
16. Brent MM, Anand R, and Marmorstein R. Structural basis for DNA recognition by FoxO1 and its regulation by posttranslational modification. Structure 16: 1407-1416, 2008.
17. Brownawell AM, Kops GJ, Macara IG, and Burgering BM. Inhibition of nuclear import by protein kinase B (Akt) regulates the subcellular distribution and activity of the forkhead transcription factor AFX. Mol Cell Biol 21: 3534-3546, 2001.
18. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J, and Greenberg ME. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96: 857-868, 1999.
19. Brunet A, Park J, Tran H, Hu LS, Hemmings BA, and Greenberg ME. Protein kinase SGK mediates survival signals by phosphorylating the forkhead transcription factor FKHRL1 (FOXO3a). Mol Cell Biol 21: 952-965, 2001.
20. Clark KL, Halay ED, Lai E, and Burley SK. Cocrystal structure of the HNF-3/fork head DNA-recognition motif resembles histone H5. Nature 364: 412-420, 1993.
21. Collado M, Medema RH, Garcia-Cao I, Dubuisson ML, Barradas M, Glassford J, Rivas C, Burgering BM, Serrano M, and Lam EW. Inhibition of the phosphoinositide 3-ki-nase pathway induces a senescence-like arrest mediated by p27Kip1. J Biol Chem 275: 21960-21968, 2000.
22. Dhanasekaran DN, Kashef K, Lee CM, Xu H, and Reddy EP. Scaffold proteins of MAP-kinase modules. Oncogene 26: 3185-3202, 2007.
23. Dijkers PF, Birkenkamp KU, Lam EW, Thomas NS, Lammers JW, Koenderman L, and Coffer PJ. FKHR-L1 can act as a critical effector of cell death induced by cytokine withdrawal: protein kinase B-enhanced cell survival through maintenance of mitochondrial integrity. J Cell Biol 156: 531-542, 2002.
24. Dijkers PF, Medema RH, Lammers JW, Koenderman L, and Coffer PJ. Expression of the pro-apoptotic Bcl-2 family member Bim is regulated by the forkhead transcription factor FKHR-L1. Curr Biol 10: 1201-1204, 2000.
25. Essers M, Weijzen S, de Vries-Smits A, Saarloos I, de Ruiter N, Bos J, and Burgering B. FOXO transcription factor activation by oxidative stress mediated by the small GTPase Ral and JNK. EMBO J 23: 4802-4812, 2004.
26. Figueroa C, Tarras S, Taylor J, and Vojtek AB. Akt2 negatively regulates assembly of the POSH-MLK-JNK signaling complex. J Biol Chem 278: 47922-47927, 2003.
27. Fu W, Ma Q, Chen L, Li P, Zhang M, Ramamoorthy S, Nawaz Z, Shimojima T, Wang H, Yang Y, Shen Z, Zhang Y, Zhang X, Nicosia SV, Zhang Y, Pledger JW, Chen J, and Bai W. MDM2 acts downstream of p53 as an E3 ligase to promote FOXO ubiquitination and degradation. J Biol Chem 284: 13987-14000, 2009.
28. Furukawa-Hibi Y, Yoshida-Araki K, Ohta T, Ikeda K, and Motoyama N. FOXO forkhead transcription factors induce G(2)-M checkpoint in response to oxidative stress. J Biol Chem 277: 26729-26732, 2002.
29. Furuyama T, Nakazawa T, Nakano I, and Mori N. Identification of the differential distribution patterns of mRNAs and consensus binding sequences for mouse DAF-16 homologues. Biochem J 349: 629-634, 2000.
30. Gao D, Inuzuka H, Tseng A, Chin RY, Toker A, and Wei W. Phosphorylation by Akt1 promotes cytoplasmic localization of Skp2 and impairs APCCdh1-mediated Skp2 destruction. Nat Cell Biol 11: 397-408, 2009.
31. Graves JD, Gotoh Y, Draves KE, Ambrose D, Han DK, Wright M, Chernoff J, Clark EA, and Krebs EG. Caspase-mediated activation and induction of apoptosis by the mammalian Ste20-like kinase Mst1. EMBO J 17: 2224-2234, 1998.
32. Greer EL, Dowlatshahi D, Banko MR, Villen J, Hoang K, Blanchard D, Gygi SP, and Brunet A. An AMPK-FOXO pathway mediates longevity induced by a novel method of dietary restriction in C. elegans. Curr Biol 17: 1646-1656, 2007.
33. Greer EL, Oskoui PR, Banko MR, Maniar JM, Gygi MP, Gygi SP, and Brunet A. The energy sensor AMP-activated protein kinase directly regulates the mammalian FOXO3 transcription factor. J Biol Chem 282: 30107-30119, 2007.
34. Guo S, Rena G, Cichy S, He X, Cohen P, and Unterman T. Phosphorylation of serine 256 by protein kinase B disrupts transactivation by FKHR and mediates effects of insulin on insulin-like growth factor-binding protein-1 promoter activity through a conserved insulin response sequence. J Biol Chem 274: 17184-17192, 1999.
35. Hao Y, Wong R, and Feig LA. RalGDS couples growth factor signaling to Akt activation. Mol Cell Biol 28: 2851-2859, 2008.
36. Harvey K and Tapon N. The Salvador-Warts-Hippo path-way-an emerging tumour-suppressor network. Nat Rev Cancer 7: 182-191, 2007.
37. Hu MCT, Lee D-F, Xia W, Golfman LS, Ou-Yang F, Yang J-Y, Zou Y, Bao S, Hanada N, Saso H, Kobayashi R, and Hung M-C. IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a. Cell 117: 225-237, 2004.
38. Huang H, Regan KM, Lou Z, Chen J, and Tindall DJ. CDK2-dependent phosphorylation of FOXO1 as an apo-ptotic response to DNA damage. Science 314: 294-297, 2006.
39. Huang H, Regan KM, Wang F, Wang D, Smith DI, Van Deursen JMA, and Tindall DJ. Skp2 inhibits FOXO1 in tumor suppression through ubiquitin-mediated degradation. Proc Natl Acad Sci USA 102: 1649-1654, 2005.
40. Huang X, Begley M, Morgenstern KA, Gu Y, Rose P, Zhao H, and Zhu X. Crystal structure of an inactive Akt2 kinase domain. Structure 11: 21-30, 2003.
41. Jang S-W, Yang S-J, Srinivasan S, and Ye K. Akt phos-phorylates MstI and prevents its proteolytic activation, blocking FOXO3 phosphorylation and nuclear translocation. J Biol Chem 282: 30836-30844, 2007.
42. Janssens V, Longin S, and Goris J. PP2A holoenzyme assembly: in cauda venenum (the sting is in the tail). Trends Biochem Sci 33: 113-121, 2008.
43. Kaestner KH, Knochel W, and Martinez DE. Unified nomenclature for the winged helix/forkhead transcription factors. Genes Dev 14: 142-146, 2000.
44. Kageyama K, Ihara Y, Goto S, Urata Y, Toda G, Yano K, and Kondo T. Overexpression of calreticulin modulates protein kinase B/Akt signaling to promote apoptosis during cardiac differentiation of cardiomyoblast H9c2 cells. J Biol Chem 277: 19255-19264, 2002.
45. Kamagate A, Qu S, Perdomo G, Su D, Kim DH, Slusher S, Meseck M, and Dong HH. FoxO1 mediates insulin-dependent regulation of hepatic VLDL production in mice. J Clin Invest 118: 2347-2364, 2008.
46. Kim AH, Khursigara G, Sun X, Franke TF, and Chao MV. Akt phosphorylates and negatively regulates apoptosis signal-regulating kinase 1. Mol Cell Biol 21: 893-901, 2001.
47. Kim AH, Sasaki T, and Chao MV. JNK-interacting protein 1 promotes Akt1 activation. J Biol Chem 278: 29830-29836, 2003.
48. Kim AH, Yano H, Cho H, Meyer D, Monks B, Margolis B, Birnbaum MJ, and Chao MV. Akt1 regulates a JNK scaffold during excitotoxic apoptosis. Neuron 35: 697-709, 2002.
49. Kops G, Dansen T, Polderman P, Saarloos I, Wirtz K, Coffer P, Huang T, Bos J, Medema R, and Burgering B. Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress. Nature 419: 316-321, 2002.
50. Kops G, Medema R, Glassford J, Essers M, Dijkers P, Coffer P, Lam E, and Burgering B. Control of cell cycle exit and entry by protein kinase B-regulated forkhead transcription factors. Mol Cell Biol 22: 2025-2036, 2002.
51. Kops GJ, de Ruiter ND, De Vries-Smits AM, Powell DR, Bos JL, and Burgering BM. Direct control of the Forkhead transcription factor AFX by protein kinase B. Nature 398: 630-634, 1999.
52. Kukekov NV, Xu Z, and Greene LA. Direct interaction of the molecular scaffolds POSH and JIP is required for apo-ptotic activation of JNKs. J Biol Chem 281: 15517-15524, 2006.
53. Lee SR, Yang KS, Kwon J, Lee C, Jeong W, and Rhee SG. Reversible inactivation of the tumor suppressor PTEN by H2O2. J Biol Chem 277: 20336-20342, 2002.
54. Lee YH, Giraud J, Davis RJ, and White MF. c-Jun N-terminal kinase (JNK) mediates feedback inhibition of the insulin signaling cascade. J Biol Chem 278: 2896-2902, 2003.
55. Lehtinen MK, Yuan Z, Boag PR, Yang Y, Villén J, Becker EBE, DiBacco S, de la Iglesia N, Gygi S, Blackwell TK, and Bonni A. A conserved MST-FOXO signaling pathway mediates oxidative-stress responses and extends life span. Cell 125: 987-1001, 2006.
56. Lin H-K, Wang G, Chen Z, Teruya-Feldstein J, Liu Y, Chan C-H, Yang W-L, Erdjument-Bromage H, Nakayama KI, Nimer S, Tempst P, and Pandolfi PP. Phosphorylation-dependent regulation of cytosolic localization and on-cogenic function of Skp2 by Akt/PKB. Nat Cell Biol 11: 420-432, 2009.
57. Liu P, Kao TP, and Huang H. CDK1 promotes cell proliferation and survival via phosphorylation and inhibition of FOXO1 transcription factor. Oncogene 27: 4733-4744, 2008.
58. Lyons TR, Thorburn J, Ryan PW, Thorburn A, Anderson SM, and Kassenbrock CK. Regulation of the Pro-apoptotic scaffolding protein POSH by Akt. J Biol Chem 282: 21987-21997, 2007.
59. Macara IG. Transport into and out of the nucleus. Microbiol Mol Biol Rev 65: 570-594, table of contents, 2001.
60. Mamillapalli R, Gavrilova N, Mihaylova VT, Tsvetkov LM, Wu H, Zhang H, and Sun H. PTEN regulates the ubiquitin-dependent degradation of the CDK inhibitor p27(KIP1) through the ubiquitin E3 ligase SCF(SKP2). Curr Biol 11: 263-267, 2001.
61. Mammucari C, Milan G, Romanello V, Masiero E, Rudolf R, Del Piccolo P, Burden SJ, Di Lisi R, Sandri C, Zhao J, Goldberg AL, Schiaffino S, and Sandri M. FoxO3 controls autophagy in skeletal muscle in vivo. Cell Metab 6: 458-471, 2007.
62. Matsuoka S, Ballif BA, Smogorzewska A, McDonald ER 3rd, Hurov KE, Luo J, Bakalarski CE, Zhao Z, Solimini N, Lerenthal Y, Shiloh Y, Gygi SP, and Elledge SJ. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 316: 1160-1166, 2007.
63. Mattila J, Kallijärvi J, and Puig O. RNAi screening for ki-nases and phosphatases identifies FoxO regulators. Proc Natl Acad Sci USA 105: 14873-14878, 2008.
64. Medema R, Kops G, Bos J, and Burgering B. AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1. Nature 404: 782-787, 2000.
65. Modur V, Nagarajan R, Evers BM, and Milbrandt J. FOXO proteins regulate tumor necrosis factor-related apoptosis inducing ligand expression. Implications for PTEN mutation in prostate cancer. J Biol Chem 277: 47928-47937, 2002.
66. Murata H, Ihara Y, Nakamura H, Yodoi J, Sumikawa K, and Kondo T. Glutaredoxin exerts an antiapoptotic effect by regulating the redox state of Akt. J Biol Chem 278: 50226-50233, 2003.
67. Nakae J, Kitamura T, Silver DL, and Accili D. The forkhead transcription factor Foxo1 (Fkhr) confers insulin sensitivity onto glucose-6-phosphatase expression. J Clin Invest 108: 1359-1367, 2001.
68. Nakae J, Oki M, and Cao Y. The FoxO transcription factors and metabolic regulation. FEBS Lett 582: 54-67, 2008.
69. Nakamura N, Ramaswamy S, Vazquez F, Signoretti S, Loda M, and Sellers WR. Forkhead transcription factors are critical effectors of cell death and cell cycle arrest downstream of PTEN. Mol Cell Biol 20: 8969-8982, 2000.
70. Nemoto S and Finkel T. Redox regulation of forkhead proteins through a p66shc-dependent signaling pathway. Science 295: 2450-2452, 2002.
71. Nogueira V, Park Y, Chen CC, Xu PZ, Chen ML, Tonic I, Unterman T, and Hay N. Akt determines replicative senescence and oxidative or oncogenic premature senescence and sensitizes cells to oxidative apoptosis. Cancer Cell 14: 458-470, 2008.
72. Ogg S, Paradis S, Gottlieb S, Patterson GI, Lee L, Tissen-baum HA, and Ruvkun G. The Fork head transcription factor DAF-16 transduces insulin-like metabolic and longevity signals in C. elegans. Nature 389: 994-999, 1997.
73. Oh SW, Mukhopadhyay A, Svrzikapa N, Jiang F, Davis RJ, and Tissenbaum HA. JNK regulates lifespan in Cae-norhabditis elegans by modulating nuclear translocation of forkhead transcription factor/DAF-16. Proc Natl Acad Sci USA 102: 4494-4499, 2005.
74. Ozes ON, Mayo LD, Gustin JA, Pfeffer SR, Pfeffer LM, and Donner DB. NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 401: 82-85, 1999.
75. Padmanabhan S, Mukhopadhyay A, Narasimhan S, Tesz G, Czech M, and Tissenbaum H. A PP2A regulatory sub-unit regulates C. elegans insulin/IGF-1 signaling by modulating AKT-1 phosphorylation. Cell 136: 939-951, 2009.
76. Paradis S and Ruvkun G. Caenorhabditis elegans Akt/PKB transduces insulin receptor-like signals from AGE-1 PI3 kinase to the DAF-16 transcription factor. Genes Dev 12: 2488-2498, 1998.
77. Park H-S, Kim M-S, Huh S-H, Park J, Chung J, Kang SS, and Choi E-J. Akt (protein kinase B) negatively regulates SEK1 by means of protein phosphorylation. J Biol Chem 277: 2573-2578, 2002.
78. Plas DR and Thompson CB. Akt activation promotes degradation of tuberin and FOXO3a via the proteasome. J Biol Chem 278: 12361-12366, 2003.
79. Raabe M, Veniant MM, Sullivan MA, Zlot CH, Bjorkegren J, Nielsen LB, Wong JS, Hamilton RL, and Young SG. Analysis of the role of microsomal triglyceride transfer protein in the liver of tissue-specific knockout mice. J Clin Invest 103: 1287-1298, 1999.
80. Raman M, Earnest S, Zhang K, Zhao Y, and Cobb MH. TAO kinases mediate activation of p38 in response to DNA damage. EMBO J 26: 2005-2014, 2007.
81. Ramaswamy S, Nakamura N, Sansal I, Bergeron L, and Sellers WR. A novel mechanism of gene regulation and tumor suppression by the transcription factor FKHR. Cancer Cell 2: 81-91, 2002.
82. Rena G, Guo S, Cichy SC, Unterman TG, and Cohen P. Phosphorylation of the transcription factor forkhead family member FKHR by protein kinase B. J Biol Chem 274: 17179-17183, 1999.
83. Rena G, Prescott AR, Guo S, Cohen P, and Unterman TG. Roles of the forkhead in rhabdomyosarcoma (FKHR) phosphorylation sites in regulating 14-3-3 binding, trans-activation and nuclear targetting. Biochem J 354: 605-612, 2001.
84. Rena G, Woods YL, Prescott AR, Peggie M, Unterman TG, Williams MR, and Cohen P. Two novel phosphorylation sites on FKHR that are critical for its nuclear exclusion. EMBO J 21: 2263-2271, 2002.
85. Rokudai S, Fujita N, Kitahara O, Nakamura Y, and Tsuruo T. Involvement of FKHR-dependent TRADD expression in chemotherapeutic drug-induced apoptosis. Mol Cell Biol 22: 8695-8708, 2002.
86. Sandri M, Sandri C, Gilbert A, Skurk C, Calabria E, Picard A, Walsh K, Schiaffino S, Lecker SH, and Goldberg AL. Foxo transcription factors induce the atrophy-related ubi-quitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 117: 399-412, 2004.
87. Schachter KA, Du Y, Lin A, and Gallo KA. Dynamic positive feedback phosphorylation of mixed lineage kinase 3 by JNK reversibly regulates its distribution to Triton-soluble domains. J Biol Chem 281: 19134-19144, 2006.
88. Schmidt M, Fernandez de Mattos S, Van der Horst A, Klompmaker R, Kops G, Lam E, Burgering B, and Medema R. Cell cycle inhibition by FoxO forkhead transcription factors involves downregulation of cyclin D. Mol Cell Biol 22: 7842-7852, 2002.
89. Schmoll D, Walker KS, Alessi DR, Grempler R, Burchell A, Guo S, Walther R, and Unterman TG. Regulation of glu-cose-6-phosphatase gene expression by protein kinase Balpha and the forkhead transcription factor FKHR. Evidence for insulin response unit-dependent and -independent effects of insulin on promoter activity. J Biol Chem 275: 36324-36333, 2000.
90. Singh A, Ye M, Bucur O, Zhu S, Santos MT, Rabinovitz I, Wei W, Gao D, Hahn WC, and Khosravi-Far R. Protein phosphatase 2A reactivates FOXO3a through a dynamic interplay with 14-3-3 and AKT. Mol Biol Cell 21: 1140-1152, 2010.
91. Song JJ and Lee YJ. Cross-talk between JIP3 and JIP1 during glucose deprivation: SEK1-JNK2 and Akt1 act as mediators. J Biol Chem 280: 26845-26855, 2005.
92. Song JJ and Lee YJ. Dissociation of Akt1 from its negative regulator JIP1 is mediated through the ASK1-MEK-JNK signal transduction pathway during metabolic oxida-tive stress: a negative feedback loop. J Cell Biol 170: 61-72, 2005.
93. Stahl M, Dijkers P, Kops G, Lens S, Coffer P, Burgering B, and Medema R. The forkhead transcription factor FoxO regulates transcription of p27Kip1 and Bim in response to IL-2. J Immunol 168: 5024-5031, 2002.
94. Stitt TN, Drujan D, Clarke BA, Panaro F, Timofeyva Y, Kline WO, Gonzalez M, Yancopoulos GD, and Glass DJ. The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol Cell 14: 395-403, 2004.
95. Sunayama J, Tsuruta F, Masuyama N, and Gotoh Y. JNK antagonizes Akt-mediated survival signals by phosphory-lating 14-3-3. J Cell Biol 170: 295-304, 2005.
96. Takaishi H, Konishi H, Matsuzaki H, Ono Y, Shirai Y, Saito N, Kitamura T, Ogawa W, Kasuga M, Kikkawa U, and Nishizuka Y. Regulation of nuclear translocation of fork-head transcription factor AFX by protein kinase B. Proc Natl Acad Sci USA 96: 11836-11841, 1999.
97. Tang ED, Nunez G, Barr FG, and Guan KL. Negative regulation of the forkhead transcription factor FKHR by Akt. J Biol Chem 274: 16741-16746, 1999.
98. Tang TT, Dowbenko D, Jackson A, Toney L, Lewin DA, Dent AL, and Lasky LA. The forkhead transcription factor AFX activates apoptosis by induction of the BCL-6 tran-scriptional repressor. J Biol Chem 277: 14255-14265, 2002.
99. Tissenbaum HA and Ruvkun G. An insulin-like signaling pathway affects both longevity and reproduction in Cae-norhabditis elegans. Genetics 148: 703-717, 1998.
100. Tran H, Brunet A, Grenier JM, Datta SR, Fornace AJ, DiS-tefano PS, Chiang LW, and Greenberg ME. DNA repair pathway stimulated by the forkhead transcription factor FOXO3a through the Gadd45 protein. Science 296: 530-534, 2002.
101. Tsai W-B, Chung YM, Takahashi Y, Xu Z, and Hu MC-T. Functional interaction between FOXO3a and ATM regulates DNA damage response. Nat Cell Biol 10: 460-467, 2008.
102. Urano F, Wang X, Bertolotti A, Zhang Y, Chung P, Harding HP, and Ron D. Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1. Science 287: 664-666, 2000.
103. Van der Horst A, de Vries-Smits A, Brenkman A, Van Triest M, Van den Broek N, Colland F, Maurice M, and Burgering B. FOXO4 transcriptional activity is regulated by mono-ubiquitination and USP7/HAUSP. Nat Cell Biol 8: 1064-1073, 2006.
104. Walter PL, Steinbrenner H, Barthel A, and Klotz LO. Stimulation of selenoprotein P promoter activity in hepatoma cells by FoxO1a transcription factor. Biochem Biophys Res Commun 365: 316-321, 2008.
105. Wang MC, Bohmann D, and Jasper H. JNK extends life span and limits growth by antagonizing cellular and organism-wide responses to insulin signaling. Cell 121: 115-125, 2005.
106. Weigelt J, Climent I, Dahlman-Wright K, and Wikstrom M. Solution structure of the DNA binding domain of the human forkhead transcription factor AFX (FOXO4). Biochemistry 40: 5861-5869, 2001.
107. Woods YL, Rena G, Morrice N, Barthel A, Becker W, Guo S, Unterman TG, and Cohen P. The kinase DYRK1A phos-phorylates the transcription factor FKHR at Ser329 in vitro, a novel in vivo phosphorylation site. Biochem J 355: 597-607, 2001.
108. Xie D, Gore C, Zhou J, Pong R-C, Zhang H, Yu L, Vessella RL, Min W, and Hsieh J-T. DAB2IP coordinates both PI3K-Akt and ASK1 pathways for cell survival and apoptosis. Proc Natl Acad Sci USA 106: 19878-19883, 2009.
109. Xu Z, Kukekov NV, and Greene LA. Regulation of apo-ptotic c-Jun N-terminal kinase signaling by a stabilization-based feed-forward loop. Mol Cell Biol 25: 9949-9959, 2005.
110. Yalcin S, Zhang X, Luciano J, Mungamuri S, Marinkovic D, Vercherat C, Sarkar A, Grisotto M, Taneja R, and Ghaffari S. Foxo3 is essential for the regulation of ataxia telangiec-tasia mutated and oxidative stress-mediated homeostasis of hematopoietic stem cells. J Biol Chem 283: 25692-25705, 2008.
111. Yamagata K, Daitoku H, Takahashi Y, Namiki K, Hisatake K, Kako K, Mukai H, Kasuya Y, and Fukamizu A. Arginine methylation of FOXO transcription factors inhibits their phosphorylation by Akt. Mol Cell 32: 221-231, 2008.
112. Yan L, Lavin VA, Moser LR, Cui Q, Kanies C, and Yang E. PP2A regulates the pro-apoptotic activity of FOXO1. J Biol Chem 283: 7411-7420, 2008.
113. Yang J-Y, Zong CS, Xia W, Yamaguchi H, Ding Q, Xie X, Lang J-Y, Lai C-C, Chang C-J, Huang W-C, Huang H, Kuo H-P, Lee D-F, Li L-Y, Lien H-C, Cheng X, Chang K-J, Hsiao C-D, Tsai F-J, Tsai C-H, Sahin AA, Muller WJ, Mills GB, Yu D, Hortobagyi GN, and Hung M-C. ERK promotes tu-morigenesis by inhibiting FOXO3a via MDM2-mediated degradation. Nat Cell Biol 10: 138-148, 2008.
114. Yeh E, Cunningham M, Arnold H, Chasse D, Monteith T, Ivaldi G, Hahn WC, Stukenberg PT, Shenolikar S, Uchida T, Counter CM, Nevins JR, Means AR, and Sears R. A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells. Nat Cell Biol 6: 308-318, 2004.
115. Yoshimochi K, Daitoku H, and Fukamizu A. PCAF represses transactivation function of FOXO1 in an acetyl-transferase-independent manner. J Recept Signal Transduct Res 30: 43-49, 2010.
116. Yuan Z, Becker EBE, Merlo P, Yamada T, DiBacco S, Konishi Y, Schaefer EM, and Bonni A. Activation of FOXO1 by Cdk1 in cycling cells and postmitotic neurons. Science 319: 1665-1668, 2008.
117. Yuan Z, Kim D, Shu S, Wu J, Guo J, Xiao L, Kaneko S, Coppola D, and Cheng JQ. Phosphoinositide 3-kinase/Akt inhibits MST1-mediated pro-apoptotic signaling through phosphorylation of threonine 120. J Biol Chem 285: 3815-3824, 2010.
118. Zhang H, Zhang R, Zhang H, Lin Y, Li J, Pober JS, and Min W. RIP1-mediated AIP1 phosphorylation at a 14-3-3-bind-ing site is critical for tumor necrosis factor-induced ASK1-JNK/p38 activation. J Biol Chem 282: 14788-14796, 2007.
119. Zhang X, Gan L, Pan H, Guo S, He X, Olson ST, Mesecar A, Adam S, and Unterman TG. Phosphorylation of serine 256 suppresses transactivation by FKHR (FOXO1) by multiple mechanisms. Direct and indirect effects on nuclear/cyto-plasmic shuttling and DNA binding. J Biol Chem 277: 45276-45284, 2002.
120. Zhao J, Brault JJ, Schild A, Cao P, Sandri M, Schiaffino S, Lecker SH, and Goldberg AL. FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells. Cell Metab 6: 472-483, 2007.